EMBO Molecular Medicine

Springer Nature

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

EMBO Molecular Medicine is an open-access journal published by Springer Nature in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 7,028 EUR. Declared review time at DOAJ: 26 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
1757-4676 · 1757-4684
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
7,028 EUR
Articles in DOAJ
2027
Declared review time
26 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2012-08-27
  • MEDLINE · 2009-01-01
  • PUBMED · 2016-01-01
Indexing
DOAJ · MEDLINE · PUBMED
APC
7,028 EUR
Declared review time (DOAJ)
26 weeks
Actual review time (measured)
180 days received→accepted — computed from PubMed (n=92)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

2027

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

26weeks

Works in OpenAlex

2389

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

187

i10-index

1638

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2012-08-27
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
95%
ORCID iDs in current deposits
100%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Molecular medicineEuropean Molecular Biology Organization molecular medicine
Source type
journal
NLM unique ID (PubMed)
101487380
Classification4

Subjects (DOAJ)

Medicine: Medicine (General)Science: Biology (General): Genetics

LCC codes

R5-920QH426-470

Subject areas

  • Mitochondrial Function and Pathology
  • Mitochondrial Function and Pathology
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • RNA modifications and cancer
  • RNA modifications and cancer
Show all subjects (50)
  • Alzheimer's disease research and treatments
  • Alzheimer's disease research and treatments
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • CAR-T cell therapy research
  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Genetics and Neurodevelopmental Disorders
  • Genetics and Neurodevelopmental Disorders
  • Immunotherapy and Immune Responses
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Endoplasmic Reticulum Stress and Disease
  • Endoplasmic Reticulum Stress and Disease
  • Virus-based gene therapy research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Virus-based gene therapy research
  • Ubiquitin and proteasome pathways
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Ubiquitin and proteasome pathways
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • RNA regulation and disease
  • RNA regulation and disease
  • Immune cells in cancer
  • RNA Research and Splicing
  • Muscle Physiology and Disorders
  • Immune cells in cancer
  • RNA Research and Splicing
  • Muscle Physiology and Disorders
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms

Keywords (DOAJ)

  • molecular medicine
  • cell biology
  • translational medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: